Randomized trial of oxytocin alone and with propranolol in the management of dysfunctional labor

Obstetrics and Gynecology

Volumn 88, Issue 4, 1996, Pages 517-520

  Sanchez Ramos, Luis ^a,b   Quillen, Mary Jane ^a   Kaunitz, Andrew M ^a  

^a UNIVERSITY OF FLORIDA HEALTH   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; OXYTOCIN; PLACEBO; PROPRANOLOL;

ADULT; APGAR SCORE; ARTICLE; CESAREAN SECTION; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DYSTOCIA; EPIDURAL ANESTHESIA; FEMALE; HOSPITAL ADMISSION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MATERNAL MORBIDITY; NEWBORN INTENSIVE CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; UTERINE CERVIX DILATATION; UTERUS CONTRACTILITY;

EID: 0029839360     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1016/0029-7844(96)00223-2     Document Type: Article

References (16)

1. NIH Consensus Development Task Force. Statement on cesarean childbirth. Am J Obstet Gynecol 1981;139:902-9.
2. Consensus Conference Report. Indications for cesarean section: Final statement of the panel of the National Consensus Conference on Aspects of Cesarean Birth. Can Med Assoc J 1986;134:1348-52.
3. Neuhoff O, Shannon Burke M, Porreco RP. Cesarean birth for failed progress in labor. Obstet Gynecol 1989;73:915-20.
4. Soliman SRH, Burrows RF. Cesarean section: Analysis of the experience before and after the National Consensus Conference on Aspects of Cesarean Birth. Can Med Assoc J 1993;148:1315-27.
5. Wansbrough H, Nakanishi H, Wood C. The effect of adrenergic receptor blocking drugs on the human uterus. J Obstet Gynaecol Br Commw 1968;75:189-98.
6. Mahon WA, Reid DWJ, Day RA. The in vivo effects of beta adrenergic stimulation and blockade on the human uterus at term. J Pharmacol Exp Ther 1967;156:178-85.
7. Barden TP, Stander RW. The effects of propranolol upon uterine activity in term human pregnancy. J Reprod Med 1969;2:188-95.
8. Mitrani A, Oettinger M, Abinader EG, Klein A. Use of propranolol in dysfunctional labor. Br J Obstet Gynaecol 1975;82:651-5.
9. Friedman EA. Labor: Clinical evaluation and management. 2nd ed. New York: Appleton-Century-Crofts, 1978.
10. American College of Obstetricians and Gynecologists. Induction and augmentation of labor. ACOG technical bulletin no. 157. Washington, DC: American College of Obstetricians and Gynecologists, 1991.
11. Caldeyro-Barcia R, Sica-Bianco Y, Poseiro JJ, Gonzalez-Panizza VH, Mendez-Bauer C, Fielitz C. A quantitative study of the action of synthetic oxytocin on the pregnant human uterus. J Pharmacol Exp Ther 1957;121:18-31.
12. Marshall JM. Effects of catecholamines on the smooth muscle of the female reproductive tract. Ann Rev Pharmacol 1973;13:19-32.
13. Garcia CR, Garcia ES. Epinephrine-like substances in the blood and their relation to uterine inertia. Am J Obstet Gynecol 1955;69: 812-7.
14. Stone ML, Piliero SL, Hammer H, Portnoy A. Epinephrine and norepinephrine in pregnancy. Obstet Gynecol 1960;16:674-8.
15. Brundin J, Engstrom L. Urinary excretion of free catecholamines during spontaneous and oxytocin-induced labor. Obstet Gynecol 1961;17:99-102.
16. Smith YR, Dombrowski MP, Leach KC, Hurd WW. Decrease in myometrial beta-adrenergic receptors with prenatal cocaine use. Obstet Gynecol 1995;85:357-60.